Finance

Fed officials expected to cut rates only once in 2024

Two years after launching an aggressive fight against inflation and one year after leaving its benchmark interest rate at a near-quarter-century high, the Federal Reserve...

5 things to know before the stock market opens Monday, July 29

Here are five key things investors need to know to start the trading day:1. Ending on a positive noteAll the major indexes surged...

Alliance Resource Partners posts worse-than-expected Q2 results as coal sales volumes decline By Investing.com

TULSA, Okla. - Alliance Resource (NASDAQ:) Partners, L.P. (NASDAQ: ARLP) today reported a shortfall in earnings and revenue for the second...

With 99 days to go, Trump’s camp is suddenly afraid that victory is slipping away

Barely a week ago, a sense of inevitability hung over the U.S. presidential election. Donald Trump’s allies gleefully predicted a landslide victory during a Republican...

As fighting rages, displaced Gazans struggle with disease and lack of shelter By Reuters

By Nidal al-Mughrabi and Ramadan Abed CAIRO/DEIR AL-BALAHA, Gaza Strip (Reuters) - Thousands of Palestinians fled a community in the central Gaza...

Italy’s prime minister Meloni vows to reset relations with China and signs a three-year action plan in the midst of an EU-China trade war

Italy and China signed a three-year action plan on Sunday to implement past agreements and experiment with new forms of cooperation, Italy’s Prime...

NEW GOLD ANNOUNCES OPERATIONS AT THE RAINY RIVER MINE HAVE RESUMED

NEW GOLD ANNOUNCES OPERATIONS AT THE RAINY RIVER MINE HAVE RESUMED https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg Source link Investing.com

Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

Novo Nordisk, the Danish pharma giant, has seen its fortunes reach astronomical heights since its drugs, Ozempic and Wegovy, took off. Its shares...

Bristol-Myers Squibb stock faces downgrade due to long-term visibility issues

On Monday, Barclays adjusted its stance on Bristol-Myers Squibb Co. (NYSE:), downgrading the pharmaceutical giant's stock from Equalweight to Underweight while maintaining a...

Latest articles

spot_imgspot_img